2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P43] Poster Session 43　Hepatobiliary/Pancreatic Cancer（Pancreatic Cancer 1）

[P43-5] Nal-IRI/5-FU/LV, modified FOLFIRINOX, and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer

○Shun Tezuka, Makoto Ueno, Tomomi Hamaguchi, Yui Yamachika, Ritsuko Oishi, Shuhei Nagashima, Taito Fukushima, Satoshi Kobayashi, Manabu Morimoto (Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password